tyrosine has been researched along with Fabry Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aerts, JM; Hollak, CE; Pennathur, S; Shayman, JA; Shu, L; Smid, BE; Vivekanandan-Giri, A | 1 |
| Grünfeld, JP; Joly, DA | 1 |
| Chimenti, C; De Paulis, R; Frustaci, A; Russo, MA; Scopelliti, F; Tafani, M; Verardo, R; Villanova, L; Vulpis, E | 1 |
| Barschak, AG; Biancini, GB; Deon, M; Giugliani, R; Jardim, LB; Manfredini, V; Netto, CB; Ribas, GS; Rodrigues, DB; Vanzin, CS; Vargas, CR | 1 |
| Endreffy, E; László, A; Morvai, L; Raffai, S; Sallay, E; Török, E; Török, L; van Amstel, JK | 1 |
| Groth, CG; Ringdén, O | 1 |
| François, J | 1 |
1 review(s) available for tyrosine and Fabry Disease
| Article | Year |
|---|---|
Transplantation in relation to the treatment of inherited disease.
Topics: alpha 1-Antitrypsin Deficiency; Amyloidosis; Bone Marrow Transplantation; Fabry Disease; Gaucher Disease; Genetic Diseases, Inborn; Gout; Granulomatous Disease, Chronic; Hemoglobinopathies; Hemophilia A; Hepatolenticular Degeneration; Humans; Immunologic Deficiency Syndromes; Kidney Transplantation; Leukodystrophy, Metachromatic; Liver Transplantation; Lymphocytes; Metabolism, Inborn Errors; Mucopolysaccharidoses; Nephritis, Hereditary; Niemann-Pick Diseases; Osteopetrosis; Oxalates; Oxalic Acid; Transplantation; Tyrosine; Uremia | 1984 |
6 other study(ies) available for tyrosine and Fabry Disease
| Article | Year |
|---|---|
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease.
Topics: Adolescent; Adult; alpha-Galactosidase; Animals; Biomarkers; Case-Control Studies; Cell Line; Disease Models, Animal; Endothelial Cells; Fabry Disease; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nitric Oxide Synthase Type III; RNA, Small Interfering; Tyrosine; Vascular Diseases; Young Adult | 2014 |
3-Nitrotyrosine as a biomarker for vascular involvement in Fabry disease.
Topics: Animals; Fabry Disease; Humans; Male; Tyrosine; Vascular Diseases | 2014 |
Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy.
Topics: Adult; Aged; Apoptosis; Fabry Disease; Female; Humans; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Tyrosine | 2015 |
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy.
Topics: Adult; alpha-Galactosidase; Antioxidants; Catalase; Enzyme Replacement Therapy; Erythrocytes; Fabry Disease; Female; Glutathione; Glutathione Peroxidase; Humans; Inflammation; Interleukin-6; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase; Trihexosylceramides; Tumor Necrosis Factor-alpha; Tyrosine; Young Adult | 2012 |
Mutation analysis of alpha-galactosidase a gene in Hungarian Fabry patients.
Topics: Adult; alpha-Galactosidase; Aspartic Acid; Codon; DNA Mutational Analysis; Exons; Fabry Disease; Humans; Male; Mutation, Missense; Polymerase Chain Reaction; Tyrosine | 2012 |
Metabolic disorders and corneal changes.
Topics: Amino Acid Metabolism, Inborn Errors; Amyloidosis; Cornea; Corneal Dystrophies, Hereditary; Dysautonomia, Familial; Fabry Disease; Glycogen Storage Disease; Humans; Lipid Metabolism, Inborn Errors; Metabolism, Inborn Errors; Mucolipidoses; Mucopolysaccharidoses; Tyrosine | 1981 |